Select TransactionsSee More Transactions »
$35,500,000

Acquisition by Ligand
$35,500,000

Series B Preferred Stock
 

Spinout from Mount Sinai Health System
$2,100,000,000

Partnership with AstraZeneca
$250,000,000

Fairness Opinion


Merger with Daré
$320,000,000

Acquisition of Zoladex


Merger with Capnia
$476,000,000

Acquisition of Performance Optics

Aquilo Partners is a life science investment bank specializing in mergers & acquisitions, licensing/partnership transactions and private placements. On each transaction, we devote a senior team of bankers committed to a transparent, thoughtful approach to success. Our collective life science banking experience includes:

  • Advising on more than $15 billion in M&A and partnering transactions; raising over $8 billion in capital

  • Maintaining top-tier relationships throughout the global life science industry
  • Biotechnology, big pharma, specialty pharma, medical devices, research tools and diagnostics